CN102416152B

CN102416152B - Medicament for treating asthma

Info

Publication number: CN102416152B
Application number: CN 201110402570
Authority: CN
Inventors: 黄炳炎
Original assignee: Individual
Current assignee: Individual
Priority date: 2011-12-07
Filing date: 2011-12-07
Publication date: 2013-03-06
Anticipated expiration: 2031-12-07
Also published as: CN102416152A

Abstract

The invention relates to a medicament for treating asthma. The medicament is prepared from the following bulk pharmaceuticals in parts by weight: 10 parts of honeysuckle flower, 15 parts of heartleaf houttuynia herb, 12 parts of platycodon root, 8 parts of blackberry lily, 8 parts of prepared pinellia tuber, 10 parts of trichosanthes bark, 7 parts of Chinese ephedra, 8 parts of cassia twig, 8 parts of apricot kernel, 10 parts of white mustard seed, 12 parts of crude white paeony root, 12 parts of willowleaf swallowwort rhizome, 10 parts of whiteflower hogfennel root, 10 parts of fineleaf schizonepeta herb, 7 parts of baikal skullcap root, 15 parts of Japanese thistle herb or root, 10 parts of fructus gardenia, 21 parts of gypsum, 8 parts of dried orange peel, 7 parts of officinal magnolia bark, 20 parts of red date, 10 parts of ginger and 5 parts of liquoric root. As proved, the medicament has the characteristics of capability of treating both principal and secondary aspects of a disease, quick response, good curative effect and no toxic or side effect, and has a short treatment course and low cost.

Description

A kind of medicament for the treatment of asthma

Technical field

The present invention relates to field of medicaments, relate in particular to a kind of medicament that is used for the treatment of asthma.

Background technology

Asthma (bronchial asthma) is by the various kinds of cell chronic airway inflammation that participates in of mastocyte, eosinophilic granulocyte and T lymphocyte particularly; This kind inflammation can cause repeatedly the symptoms such as the panting of outbreak, tachypnea, uncomfortable in chest and cough in the susceptible person, how to occur at night or morning; This type of symptom is often limited with extensive and changeable exhalation flow rate, but natural remission or alleviate through treatment partly; This kind symptom also increases multiple stimulating factor reactivity with air flue.

In order to solve these miseries, people have carried out a large amount of research, but therapeutic effect is not desirable especially.

Summary of the invention

The purpose of this invention is to provide a kind of medicament that is used for the treatment of asthma.

The present invention also aims to provide a kind of medicament for the treatment of asthma, it is to be made by the following raw material medicaments in part by weight meter: Flos Lonicerae 10, Herba Houttuyniae 15, Radix Platycodonis 12, Rhizoma Belamcandae 8, Rhizoma Pinelliae Preparata 8, Pericarpium Trichosanthis 10, Herba Ephedrae 7, Ramulus Cinnamomi 8, Semen Armeniacae Amarum 8, Semen Sinapis Albae 10, Radix Paeoniae Alba 12, Rhizoma Cynanchi Stauntonii 12, Radix Peucedani 10, Herba Schizonepetae 10, Radix Scutellariae 7, Radix Cirsii Japonici 15, SHANZHIZI 10, Gypsum Fibrosum 21, Pericarpium Citri Reticulatae 8, Cortex Magnoliae Officinalis 7, Fructus Jujubae 20, Rhizoma Zingiberis Recens 10 and Radix Glycyrrhizae 5.

Preferably, described medicament is tablet, dispersible tablet, decoction or capsule.

Wherein, Radix Peucedani:

[English name] Root of Whiteflower Hogfennel, Root of Common Hogfennel, Common HogfenneI Root

[Latin plant animal mineral name] 1.Peucedanum praeruptorum Dunn

[Latin literary fame] Radix Peucedani1.Radix Peucedani Praeruptori

The inventor is medical old and well-known family, and medicament of the present invention is the crystallization of the inventor's many years of experience, medicament empirical tests of the present invention, and the characteristics that have treating both the principal and secondary aspects of a disease, rapid-action, good effect, have no side effect, and short treating period, expense are low.

The specific embodiment

Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.

The preparation of embodiment 1 decoction of the present invention

Extracting honeysuckle 100 grams, Herba Houttuyniae 150 grams, Radix Platycodonis 120 grams, Rhizoma Belamcandae 80 grams, Rhizoma Pinelliae Preparata 80 grams, Pericarpium Trichosanthis 100 grams, Herba Ephedrae 70 grams, Ramulus Cinnamomi 80 grams, Semen Armeniacae Amarum 80 grams, Semen Sinapis Albae 100 grams, Radix Paeoniae Alba 120 grams, Rhizoma Cynanchi Stauntonii 120 grams, Radix Peucedani 100 grams, Herba Schizonepetae 100 grams, Radix Scutellariae 70 grams, Radix Cirsii Japonici 150 grams, SHANZHIZI 100 grams, Gypsum Fibrosum 210 grams, Pericarpium Citri Reticulatae 80 grams, Cortex Magnoliae Officinalis 70 grams, Fructus Jujubae 200 grams, Rhizoma Zingiberis Recens 100 grams and Radix Glycyrrhizae 50 grams, the water that adds 2000 milliliters, 80 ℃ of lower heating 3 hours, filter.Filtrate is concentrated into 500 milliliters, is cooled to room temperature, namely get decoction of the present invention.

Experimental example

Diagnostic criteria:

Reference " prevention and control of bronchial asthma guide " (respirology branch of Chinese Medical Association prevention and control of bronchial asthma guide. Chinese tuberculosis and breathing magazine, 1997,20 (5): 261.) Plays, and take the photograph sheet through x-ray, the inspections such as routine blood test are diagnosed as bronchial asthma.Tcm diagnosis meet " new Chinese medicine guideline of clinical investigations " (Ministry of Health of the People's Republic of China. the new Chinese medicine guideline of clinical investigations. the 1st volume. Nanjing: publishing house of Nanjing University, 1994.), card belongs to the hot cooked food lung of expectorant.Clinical manifestation: cough and asthma, the gurgling with sputum sound, the yellow thickness of expectorant, expectorant is not smooth less, and unhappy in the heart, can not crouch night, red tongue yellow and greasy fur, slippery and rapid pulse.

Physical data

Observe case and be the out-patient of the court, male 32 examples of totally 50 examples, women 18 examples, age 13-66 year, 35.5 years old mean age, the course of disease 3 months-20 years.

Therapeutic Method:

Use the decoction of preparation among the embodiment 1, once a day, each serving with 30 milliliters, treated continuously for two weeks.

Efficacy assessment standard:

Recovery from illness: asthma complete obiteration, not morbidity more than half a year; Take a turn for the better: asthma obviously alleviates; Invalid: symptom after the treatment, sign is without improvement.

Efficacy result:

Through treatment, 50 people reach the recovery from illness standard, and do not find obvious untoward reaction in therapeutic process.

Claims

1. medicament for the treatment of asthma, it is to be made by the following raw material medicaments in part by weight meter: Flos Lonicerae 10, Herba Houttuyniae 15, Radix Platycodonis 12, Rhizoma Belamcandae 8, Rhizoma Pinelliae Preparata 8, Pericarpium Trichosanthis 10, Herba Ephedrae 7, Ramulus Cinnamomi 8, Semen Armeniacae Amarum 8, Semen Sinapis Albae 10, Radix Paeoniae Alba 12, Rhizoma Cynanchi Stauntonii 12, Radix Peucedani 10, Herba Schizonepetae 10, Radix Scutellariae 7, Radix Cirsii Japonici 15, SHANZHIZI 10, Gypsum Fibrosum 21, Pericarpium Citri Reticulatae 8, Cortex Magnoliae Officinalis 7, Fructus Jujubae 20, Rhizoma Zingiberis Recens 10 and Radix Glycyrrhizae 5.

2. the medicament for the treatment of asthma according to claim 1 is characterized in that, described medicament is tablet, decoction or capsule.